S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:ISO

IsoPlexis (ISO) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.76
$0.76
50-Day Range
$0.74
$1.13
52-Week Range
$0.60
$5.10
Volume
N/A
Average Volume
68,375 shs
Market Capitalization
$30.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ISO stock logo

About IsoPlexis Stock (NASDAQ:ISO)

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.

ISO Stock News Headlines

the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
IsoPlexis Corporation
the most reliable asset on earth is making a comeback
Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal.
10-Q: PHENOMEX INC.
PhenomeX Reports First Quarter 2023 Financial Results
PhenomeX Strengthens Commercial Leadership Team
IsoPlexis Reports Preliminary Full Year 2022 Revenue
See More Headlines
Receive ISO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IsoPlexis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:ISO
Fax
N/A
Employees
459
Year Founded
N/A

Profitability

Net Income
$-106,000,000.00
Net Margins
-632.41%
Pretax Margin
-632.40%

Debt

Sales & Book Value

Annual Sales
$16.76 million
Book Value
$1.04 per share

Miscellaneous

Free Float
37,218,000
Market Cap
$30.28 million
Optionable
Not Optionable
Beta
1.32
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Sean Mackay (Age 40)
    Co-Founder, CEO, Pres & Director
    Comp: $635.55k
  • Mr. John R. Strahley CPA (Age 55)
    Chief Financial Officer
    Comp: $444.11k
  • Mr. Rong Fan
    Co-Founder & Chairman of Scientific Advisory Board
  • Mr. Jon Chen
    VP of Scientific Alliance Technology & Co-Founder
  • Mr. Anthony Catalano
    Sr. VP of Operations
  • Mr. Rajesh T. Khakhar
    VP of Fin. & Principal Accounting Officer
  • Ms. Jing Zhou M.D. (Age 52)
    Ph.D., Chief Scientific Officer
  • Mr. Richard W. Rew II (Age 54)
    Sr. VP, Gen. Counsel & Sec.
  • Ms. Verna Siu
    Sr. VP of Sales Operations
  • Ms. Carrie Carter
    Sr. VP of People Operations

ISO Stock Analysis - Frequently Asked Questions

How were IsoPlexis' earnings last quarter?

IsoPlexis Co. (NASDAQ:ISO) released its earnings results on Wednesday, November, 10th. The company reported ($10.66) earnings per share for the quarter, missing the consensus estimate of ($0.79) by $9.87. The firm earned $4.19 million during the quarter, compared to the consensus estimate of $3.79 million. IsoPlexis had a negative net margin of 632.41% and a negative trailing twelve-month return on equity of 127.86%.

When did IsoPlexis IPO?

IsoPlexis (ISO) raised $125 million in an initial public offering on Friday, October 8th 2021. The company issued 8,333,000 shares at $14.00-$16.00 per share.

This page (NASDAQ:ISO) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners